SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001638599-18-000417
Filing Date
2018-04-05
Accepted
2018-04-05 17:23:44
Documents
2
Period of Report
2018-03-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc3_5340.html 3  
1 PRIMARY DOCUMENT doc3_5340.xml 3 2124
2 EXHIBIT 24 exhibit24.htm EX-24 3338
  Complete submission text file 0001638599-18-000417.txt   6813
Mailing Address C/O TONIX PHARMACEUTICALS HOLDING CORP 509 MADISON AVE., SUITE 306 NEW YORK NY 10022
Business Address
MATHER CHARLES E IV (Reporting) CIK: 0001563422 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38365 | Film No.: 18741459

Mailing Address 8748 TECHNOLOGY WAY RENO NV 89521
Business Address 8748 TECHNOLOGY WAY RENO NV 89521 813-766-9539
EYENOVIA, INC. (Issuer) CIK: 0001682639 (see all company filings)

IRS No.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations